Gilead’s Secrecy Over HIV Prevention Shot Sparks Global Outrage

By Staff Reporter  Gilead Sciences has come under fire after announcing a secretive deal to supply its long-acting injectable HIV prevention drug, lenacapavir (LEN-LA), to the Global Fund to Fight AIDS, Tuberculosis and Malaria. The agreement—shrouded in indefinite price secrecy—has been widely condemned by civil society organisations, health advocates, and global health experts who warn it undermines transparency, accountability, and equitable access. The Global Fund, financed by public money, has invited nine African countries—South Africa, Eswatini, Lesotho, Mozambique, Kenya, Uganda, Zambia, Zimbabwe, and Nigeria—to participate in the agreement. However, the…

Read More

Merck Foundation Trains 100 African Cardiovascular Experts

Merck Foundation, a philanthropic arm of Merck KGaA Germany in partnership with African First Ladies, Ministries of Health, Medical Societies, and Academia celebrated the World Heart Day by providing one-year Post-Graduate Diploma and two-year Master degree in Preventive Cardiovascular Medicine to 100 doctors from 25 countries in Africa and Asia. By Patricia Mashiri The initiative shows commitment towards building Cardiovascular preventive care capacity in Africa, Asia and beyond. Senator, Dr. Rasha Kelej, CEO of Merck Foundation said he was proud of the training they have been providing so far in…

Read More

#BREAKING: Lesotho Shuts Boarders As Coronavirus Fears Grow

THE government of Lesotho has with immediate effect suspended in and outbound travel as it seeks to protect its citizens from Coronavirus infection, making it the first country in Africa to issue a travel ban as a result of the pandemic. By Michael Gwarisa In a statement, Lesotho Principal Secretary and National Contact Point, Mrs Motena Tsolo said the move has been driven by the growing cases of human to human Covid-19 infections elsewhere in the world. This correspondence serves to inform the SADC Secretariat that the Lesotho Government has…

Read More